Epidemiology of COVID-19 in patients receiving renal replacement therapy in the Russian Federation: results of 2020


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This report was presented on behalf of the Presidium of the Specialized Commission on nephrology of the Expert Council of the Ministry of Health of the Russian Federation and continues the annual series of publications on the state of the nephrological service of the Russian Federation

Full Text

Restricted Access

About the authors

E. M Shilov

Sechenov First Moscow State Medical University (Sechenov University)

O. N Kotenko

Moscow City Scientific and Practical Center for Nephrology and Pathology of a Transplanted Kidney, Moscow City Clinical Hospital № 52

M. M Shilova

Pirogov Medical University

K. S Milchakov

Sechenov First Moscow State Medical University (Sechenov University)

Higher School of Healthcare Management, Institute of Leadership and Healthcare Management

E. I Rumyantseva

Sechenov First Moscow State Medical University (Sechenov University)

Higher School of Healthcare Management, Institute of Leadership and Healthcare Management

R. A Khalfin

Sechenov First Moscow State Medical University (Sechenov University)

Higher School of Healthcare Management, Institute of Leadership and Healthcare Management

References

  1. Мурашко М.А. Первая пандемия цифровой эпохи: уроки для национального здравоохранения. Национальное здравоохранение. 2020;1(1):4-8
  2. Добронравов В. А. и др. Нефрологическая служба в условиях пандемии COVID-19 (позиция Ассоциации нефрологов). Нефрология. 2021;25(1):9 17
  3. Шилов Е.М., Котенко О.Н., Шилова М.М. с соавт. Нефрологическая служба Российской Федерации в 2019-2020 гг.: отчет Президиума Профильной комиссии по нефрологии Экспертного совета Минздрава России. Клиническая нефрология. 2020;1:6-14. [Shilov E.M., Kotenko O.N., Shilova M.M., Milchakov K.S., Rumyantseva E.I., Khalfin R.A. Nephrological service of the Russian Federation in 2019-2020: report of the presidium of the specialized commission on nephrology of the expert council of the ministry of health of the Russian Federation. Clinical nephrology. 2020;1:6-14 (In Russ.)].
  4. Андрусев А.М., Томилина Н.А., Перегудова Н.Г. с соавт. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации 2014-2018 гг. Отчет по данным Общероссийского Регистра заместительной почечной терапии Российского диализного общества. Нефрология и диализ. 2020;22(1):1-71 [Andrusev A.M., Tomilina N.A., Peregudova N.G. et al. Replacement therapy of end-stage renal disease in the Russian Federation 2014-2018. Report on the data of the Russian Renal Replacement Therapy Register of the Russian Dialysis Society. Nephrology and dialysis. 2020; 22 (1): 1-71 (In Russ.)].
  5. Бетес М. Дисфункция иммунных клеток и воспаление при терминальной стадии почечной недостаточности. Нат. Рев. Нефрол. 2013;9(5):255-65. [Betes M. Immune cell dysfunction and inflammation in end-stage renal disease. Nephrology. 2013; 9 (5): 255-65. (In Russ.)].
  6. Akiyama S., Hamdeh S., Micic D., Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2020.
  7. Li L., Huang T., Wang Y., Wang Z., Liang Y., Huang T. et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of metaanalysis. J Med Virol. 2020;92(6):577-83.
  8. Meyerowitz-Katz G., Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. Int J Infect Dis. 2020;101:138-48.
  9. Khalili M., Karamouzian M., Nasiri N., Javadi S., Mirzazadeh A., Sharifi H. Epidemiological characteristics of COVID-19: a systematic review and metaanalysis. Epidemiol Infect. 2020;148:e130.
  10. Zhang J, Wu J, Sun X, Xue H, Shao J, Cai W, et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis. Epidemiol Infect. 2020;148:e106.
  11. Wu J., Zhang J., Sun X., Wang L., Xu Y., Zhang Y., et al. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection. Diabetes Obes Metab. 2020;22(10):1907-14.
  12. Salunke A., Nandy K., Pathak S., Shah J., Kamani M., Kottakota V. et al. Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(5):1431-37.
  13. Chronic kidney disease is a key risk / Council and the ERACODA Working Group*. Nephrol Dial Transplant. 2021;36:87-94. doi: 10.1093/ndt/gfaa314.
  14. Gansevoort R.T., Hilbrands L.B. CKD является ключевым фактором риска смертностиCOVID-19. Nat Rev Nephrol. 2020;16:705-706. https:// doi.org/10.1038/s41581-020-00349-4.
  15. Ssentongo P., Ssentongo A.E., Heilbrunn E.S., Ba D.M., Chinchilli V.M. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS ONE. 2020;15(8):e0238215. https://doi.org/10.1371/journal.pone.0238215.
  16. Nouvier M., Verger C., Fouque D. Situation of the Covid-19 epidemic in patients on peritoneal dialysis on 2020/05/15 in France according to RDPLF data-base. Journal ojficiel du Registre de Dialyse Peritoneale de Langue Frangaise RDPLF. Volume 3, n°2 , Juin 2020. https://doi.org/10.25796/ bdd.v3i2.55433.
  17. The Renal Association. COVID-19 surveillance report for renal centres in the UK2020. https://renal.org/covid-19/ra-resources-renal-professionals.
  18. Шилов Е.М., Котенко О.Н., Шилова М.М. и соавт. Нефрологическая служба Российской Федерации в 2019-2020гг.: отчет Президиума Профильной комиссии по нефрологии Экспертного совета Минздрава России. Клиническая нефрология. 2020;4:5-14

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies